PMS-IRBESARTAN-HCTZ
PHARMASCIENCE INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of PMS-IRBESARTAN-HCTZ in Canada?
A shortage of PMS-IRBESARTAN-HCTZ 25MG 300MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 4, 2026), but it has not started yet.
Why is PMS-IRBESARTAN-HCTZ not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will PMS-IRBESARTAN-HCTZ be available again?
The manufacturer's estimated resolution date is March 3, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02328534
Strength
25MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
HYDROCHLOROTHIAZIDE IRBESARTAN
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from PHARMASCIENCE INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02303299
DIN 01999648
DIN 01999656
DIN 02028174
DIN 02025337
650MG · DIN 02527901
81MG · DIN 02433044
81MG · DIN 02244993
81MG · DIN 02394790
80MG · DIN 02009013
80MG · DIN 02238545
40MG · DIN 02399393